The biggest splash this week came from Novavax, a Maryland company that landed $1.6 billion from the US government’ s Operation Warp Speed program to support manufacturing and clinical trials for its vaccine candidate. At least three key clinical studies are expected to begin later this month: Moderna’ s new trial of its experimental vaccine, which would be the…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Best’s Market Segment Outlook: AM Best’s Outlook on Germany’s Non-Life Insurance Market Remains Stable
Advisor News
- CFP Board appoints K. Dane Snowden as CEO
- TIAA unveils ‘policy roadmap’ to boost retirement readiness
- 2026 may bring higher volatility, slower GDP growth, experts say
- Why affluent clients underuse advisor services and how to close the gap
- America’s ‘confidence recession’ in retirement
More Advisor NewsAnnuity News
- Insurer Offers First Fixed Indexed Annuity with Bitcoin
- Assured Guaranty Enters Annuity Reinsurance Market
- Ameritas: FINRA settlement precludes new lawsuit over annuity sales
- Guaranty Income Life Marks 100th Anniversary
- Delaware Life Insurance Company Launches Industry’s First Fixed Indexed Annuity with Bitcoin Exposure
More Annuity NewsHealth/Employee Benefits News
- OPINION: Lawmakers should extend state assistance for health care costs
- House Dems roll out affordability plan, take aim at Reynolds' priorities
- Municipal healthcare costs loom as officials look to fiscal 2027 budget
- Free Va. clinics brace for surge
- Far fewer people buy Obamacare coverage as insurance premiums spike
More Health/Employee Benefits NewsLife Insurance News